Dhanak Dashyant 4
4 · Deciphera Pharmaceuticals, Inc. · Filed Sep 19, 2023
Insider Transaction Report
Form 4
Dhanak Dashyant
EVP & Chief Scientific Officer
Transactions
- Award
Common Stock
2023-09-15+65,900→ 65,900 total - Award
Stock Option (Right to Buy)
2023-09-15+65,900→ 65,900 totalExercise: $13.42Exp: 2033-09-14→ Common Stock (65,900 underlying) - Award
Common Stock
2023-09-15+75,000→ 140,900 total
Footnotes (3)
- [F1]The reporting person was awarded 65,900 Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. These RSUs shall vest in three equal annual installments on each of September 15, 2024, September 15, 2025 and September 15, 2026.
- [F2]The reporting person was awarded 75,000 RSUs. These RSUs will vest in two equal annual installments on each of September 15, 2024 and September 15, 2025.
- [F3]This stock option was issued pursuant to the Issuer's 2017 Stock Option and Incentive Plan. 25% of the shares underlying the option shall vest on September 15, 2024, with the remainder vesting in 36 equal monthly installments thereafter.